CANAKINUMAB_ILARIS_IMMUNOLOGY: payments to doctors
Payments that named CANAKINUMAB_ILARIS_IMMUNOLOGY as the associated drug or biological, reported under the Sunshine Act for program years 2019–2025.
- Total reported
- $22K
- Providers
- 4
- Transactions
- 13
- Average per transaction
- $1,698
The per-transaction average — $1,698 — is the number that tells you what kind of spending this is. A few dollars means meals at product presentations, reported by the thousand. Hundreds or thousands means consulting, speaking or royalty arrangements with a much smaller group of physicians. Across all 4 providers the average total is $5,517, but that average hides a very steep distribution.
Companies reporting these payments
| Company | Total reported | Share |
|---|---|---|
| Novartis Pharma AG | $22,068 | 100.0% |